Atlanta, Georgia – A Georgia State University startup company focused on developing cancer-fighting tools and treatments is making new strides by advancing its technology to the next phase of clinical trials. Georgia State’s Office of Technology Transfer reports that Da Zen Theranostics is preparing an innovation known as DZ-002 for its next significant milestone,...
Latest News
SAN DIEGO, CA ― Combining the JAK inhibitor ruxolitinib with the BCL-xL inhibitor navitoclax was twice as effective in reducing enlarged spleens – a major indicator of clinical improvement – compared with standard-of-care ruxolitinib monotherapy for adult patients with intermediate or high-risk myelofibrosis, a rare bone marrow cancer, according to...
Dresden, Germany – Tuberculosis (TB) is a prevalent infectious disease that affects millions of people each year. It was previously the leading cause of death from a single pathogen before the COVID-19 pandemic. Detecting TB early is challenging because the bacterium Mycobacterium tuberculosis (Mtb) can hide in human macrophages, which...
Copenhagen, Denmark — DNA vaccination using lupus autoantigens and interleukin-10 (IL-10, a cytokine that plays an important role in regulating the immune system) has potential as a novel therapy to induce antigen specific tolerance and may help to prevent kidney damage in patients with systemic lupus erythematosus (SLE), according to...
A group of immune cells that normally protect against inflammation in the gastrointestinal tract may have the opposite effect in multiple sclerosis (MS) and other brain inflammation-related conditions, according to a new study by Weill Cornell Medicine and NewYork-Presbyterian researchers. The results suggest that countering the activity of these cells...
Chengdu, China – HBV-related hepatocellular carcinoma poses a significant global health challenge, characterized by its cellular diversity and complex tumor immune microenvironment. The increasing unmet need in HBV-HCC treatment drives to deeper understand the role of the intricate immune microenvironment, tumor cell plasticity and dynamics of tumor evolution in HBV-associated...
Barcelona, Spain – Published today in Cancer Cell (1), results of a study directed by Joaquin Mateo, Head of the Vall d’Hebron Institute of Oncology’s (VHIO) Prostate Cancer Translational Research Group, show that DNA/RNA material contained in circulating extracellular vesicles secreted into the blood stream by tumor cells, captures cancer...
SAN DIEGO ― Two clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated early positive results from novel therapies targeting menin for the treatment of relapsed or refractory acute leukemias with specific genetic alterations. Results from the studies were shared today in oral presentations at the...
Tsukuba, Japan – Type 2 diabetes, a prominent form of diabetes, is widely recognized for its association with insulin resistance—a condition wherein insulin becomes ineffective. This ineffectiveness stems from factors such as obesity, disruption of compensatory insulin secretion by pancreatic beta cells (pancreatic beta cell dysfunction), and a decrease in...
Reston, VA — A newly developed PET imaging agent has been found to be effective in identifying medullary thyroid cancer (MTC) in preclinical and clinical studies, according to research published in the January issue of The Journal of Nuclear Medicine. The results of the studies indicate that the PET imaging agent...